General Information of Drug Transporter (DT)
DT ID DTD0034 Transporter Info
Gene Name SLC18A2
Transporter Name Vesicular amine transporter 2
Gene ID
6571
UniProt ID
Q05940
Post-Translational Modification of This DT
Overview of SLC18A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Disulfide bond X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

479

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC18A2 Lysine 479 has the potential to affect its expression or activity.

Disulfide bond

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

117

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC18A2 Cystine 117 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A2 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

324

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC18A2 Cystine 324 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

84

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC18A2 Asparagine 84 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A2 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

91

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC18A2 Asparagine 91 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

488

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC18A2 Cystine 488 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

50

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 50 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A2 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

111

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 111 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC18A2 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

119

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 119 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC18A2 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

240

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 240 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC18A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

511

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 511 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC18A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

513

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A2 Serine 513 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A2 [11]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

488

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC18A2 Cystine 488 has the potential to affect its expression or activity.
References
1 Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow. Mol Cell Proteomics. 2015 Sep;14(9):2429-40.
2 iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: Q05940)
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: VMAT2_HUMAN)
4 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8 Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.
9 Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
10 Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia. 2014 Mar;28(3):716-9.
11 Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis. Cell Death Dis. 2019 Dec 4;10(12):914.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.